Skip to content

Laparoscopic Enclosed Morcellation; Electromechanic Morcellation vs Vaginal Removal

Enclosed Electromechanical Morcellation and Vaginal Removal During Laparoscopic Myomectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02737553
Enrollment
118
Registered
2016-04-14
Start date
2016-10-31
Completion date
2020-02-29
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoma

Brief summary

Laparoscopic tissue removal is one of the most challenging parts for the laparoscopic surgery. For this reason, electromechanical morcellation has long been used to facilitate the tissue removal in gynecology. However, electromechanical morcellation has long been performed inside the abdomen without any containment. Therefore, this practice has recently undergone increased scrutiny because of important concerns related to tissue dissemination during intracorporeal power morcellation. Thus, the US Food and Drug Administration released a safety communication discouraging power morcellation in laparoscopic hysterectomy and myomectomy procedures in April 2014. As a result of this serious concern, the enclosed laparoscopic power morcellation has been come into prominence in gynecological surgery. Besides the removal of the tissues through vagina with posterior colpotomy is considered an another solution for this critical problem. In the literature the comparison for the two techniques for tissue removal is considerably scarce. Therefore researchers are aiming to prepare a trial to compare the laparoscopic enclosed electromechanical morcellation and tissue removal thorough vagina with posterior colpotomy according to surgical time, postoperative pain and postoperative sexual function.

Detailed description

In this study researchers aiming to compare the compare the laparoscopic enclosed electromechanical morcellation and tissue removal thorough vagina with posterior colpotomy according to surgical time, postoperative pain and postoperative sexual function. Patients with an indication of myomectomy, between 18 to 40 years old, without prior abdominal surgery and without suspicious of malignancy will include into the study. Anticipated number of the patients will be 60. Participants will be randomized into two groups; group 1 enclosed electromechanical morcellation will be performed to remove the myoma out of the abdominal cavity; group 2 myoma will be removed through vagina with posterior colpotomy. In group 1, after extirpation of the myoma from the uterus and repair of the uterine defect, the myoma will be removed from the abdomen with an enclosed laparoscopic electromechanical morcellation with using surgical glove. In group 2, after extirpation of myoma from uterus and repair of the uterine defect, myoma will be removed through the vagina with posterior colpotomy. In this group myoma will also be removed in a enclosed fashion with using endo bag. Tissue removal time (for group 1 removal time is decided time between the insertion and removal of the morcellation, for group two removal time is decided time between start of the posterior colpotomy and end of the closure of the posterior colpotomy), postoperative time and sexual function of the patient and any of the complications will be compared. Visual pain score and female sexual function index questionnaire will be used to assess the postoperative pain and sexual function, respectively.

Interventions

PROCEDUREEnclosed morcellation

After extirpation of the myoma from the uterus and repair of the uterine defect, the myoma will be removed from the abdomen with an enclosed laparoscopic electromechanical morcellation as described in the literature by Akdemir et al with using surgical glove (Akdemir A et. al, Innovative technique for enclosed morcellation using a surgical glove. Obstet Gynecol. 2015 May;125(5):1145-9. doi: 10.1097/AOG.0000000000000823.).

After extirpation of myoma from uterus and repair of the uterine defect, myoma will be removed through the vagina with posterior colpotomy. In this group myoma will also be removed in a enclosed fashion with using endo bag.

Sponsors

Ege University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Myoma Uteri * No prior abdominal surgery

Exclusion criteria

* Suspicious for malignancy * Prior abdominal surgery * no vaginal intercourse

Design outcomes

Primary

MeasureTime frameDescription
Operation Time1 dayTotal operation time will be compared between two groups in seconds.

Secondary

MeasureTime frameDescription
Morcellation Time1 dayAfter extirpation of the myoma in group 1 the fibroid was placed into the glove within the abdomen. The morcellation was accomplished within the completely enclosed glove. In Group 2, after extirpation of the myoma, it was removed through the vagina through posterior colpotomy. An endoscopic specimen bag was placed into the abdomen following the vaginal posterior colpotomy. Then, the fibroid was placed into the endoscopic bag within the abdomen. The specimen was removed with coring technique via scalpel. Posterior colpotomy incision was then sutured vaginally. Morcellation time is decided time between the insertion and removal of the surgical glove in group 1 and time between start of the posterior colpotomy and end of the closure of the posterior colpotomy in group 2. Tissue morcellation time compared between two groups in seconds.

Other

MeasureTime frameDescription
Postoperative Pain2 dayPostoperative pain was compared between two groups using visual analog score in 0 to 10 scale. Participants were assessed in terms of pain with the Visual Pain Scale (VAS). The participants were asked to rate current pain on a 10-cm visual analog scale (VAS), with 0 being no pain and 10 the worst pain imaginable 48 hours after operation.
Sexual Functional Assessment3 monthsSexual function will be assessed with using Female Sexual Function Index questionnaire and it will be compared between two groups. Participants were requested to fill FSFI (Female Sexual Function Index) forms to evaluate their sexual lives. The FSFI consists of 19 questions and is a validated questionnaire for the assessment of sexual function. The questions are grouped into the subdomains of libido, arousal, lubrication, orgasm, satisfaction, and pain. The total score is determined by summing up the subdomains scores. Higher scores reflect better sexual function; maximum score is 36 and minimum score is 0. For each subdomain, higher scores reflect better sexual function; maximum score is 6 and minimum score is 0 including pain, in which 0 reflects lots of pain and 6 reflects the absence of pain.

Countries

Turkey (Türkiye)

Participant flow

Pre-assignment details

Seventeen patients with prior abdominal surgery and 4 participants without previous vaginal intercourse were excluded from the study.

Participants by arm

ArmCount
Enclosed Morcellation
In this group, after extirpation of the myoma from the uterus and repair of the uterine defect, the myoma will be removed from the abdomen with an enclosed laparoscopic electromechanical morcellation as described in the literature by Akdemir et al with using surgical glove.
49
Vaginal Morcellation
In this group, after extirpation of myoma from uterus and repair of the uterine defect, myoma will be removed through the vagina with posterior colpotomy.
48
Total97

Baseline characteristics

CharacteristicEnclosed MorcellationVaginal MorcellationTotal
Age, Continuous36.8 years
STANDARD_DEVIATION 5.9
35.5 years
STANDARD_DEVIATION 3.2
36.2 years
STANDARD_DEVIATION 4.8
BMI24.6 kg/m^2
STANDARD_DEVIATION 2.9
26.6 kg/m^2
STANDARD_DEVIATION 5.2
25.6 kg/m^2
STANDARD_DEVIATION 4.3
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
49 Participants48 Participants97 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 490 / 48
other
Total, other adverse events
0 / 490 / 48
serious
Total, serious adverse events
0 / 490 / 48

Outcome results

Primary

Operation Time

Total operation time will be compared between two groups in seconds.

Time frame: 1 day

ArmMeasureValue (MEAN)Dispersion
Enclosed MorcellationOperation Time146.1 secondsStandard Deviation 31.6
Vaginal MorcellationOperation Time124.6 secondsStandard Deviation 35.4
Secondary

Morcellation Time

After extirpation of the myoma in group 1 the fibroid was placed into the glove within the abdomen. The morcellation was accomplished within the completely enclosed glove. In Group 2, after extirpation of the myoma, it was removed through the vagina through posterior colpotomy. An endoscopic specimen bag was placed into the abdomen following the vaginal posterior colpotomy. Then, the fibroid was placed into the endoscopic bag within the abdomen. The specimen was removed with coring technique via scalpel. Posterior colpotomy incision was then sutured vaginally. Morcellation time is decided time between the insertion and removal of the surgical glove in group 1 and time between start of the posterior colpotomy and end of the closure of the posterior colpotomy in group 2. Tissue morcellation time compared between two groups in seconds.

Time frame: 1 day

ArmMeasureValue (MEAN)Dispersion
Enclosed MorcellationMorcellation Time25.94 secondsStandard Deviation 8.1
Vaginal MorcellationMorcellation Time20.79 secondsStandard Deviation 6.9
Other Pre-specified

Postoperative Pain

Postoperative pain was compared between two groups using visual analog score in 0 to 10 scale. Participants were assessed in terms of pain with the Visual Pain Scale (VAS). The participants were asked to rate current pain on a 10-cm visual analog scale (VAS), with 0 being no pain and 10 the worst pain imaginable 48 hours after operation.

Time frame: 2 day

ArmMeasureValue (MEAN)Dispersion
Enclosed MorcellationPostoperative Pain1.7 score on a scaleStandard Deviation 1.6
Vaginal MorcellationPostoperative Pain1.6 score on a scaleStandard Deviation 1.38
Other Pre-specified

Sexual Functional Assessment

Sexual function will be assessed with using Female Sexual Function Index questionnaire and it will be compared between two groups. Participants were requested to fill FSFI (Female Sexual Function Index) forms to evaluate their sexual lives. The FSFI consists of 19 questions and is a validated questionnaire for the assessment of sexual function. The questions are grouped into the subdomains of libido, arousal, lubrication, orgasm, satisfaction, and pain. The total score is determined by summing up the subdomains scores. Higher scores reflect better sexual function; maximum score is 36 and minimum score is 0. For each subdomain, higher scores reflect better sexual function; maximum score is 6 and minimum score is 0 including pain, in which 0 reflects lots of pain and 6 reflects the absence of pain.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Enclosed MorcellationSexual Functional Assessment18.4 score on a scaleStandard Deviation 9.9
Vaginal MorcellationSexual Functional Assessment25.3 score on a scaleStandard Deviation 4.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026